Literature DB >> 11038272

High-throughput screening of enzyme inhibitors: simultaneous determination of tight-binding inhibition constants and enzyme concentration.

P Kuzmic1, K C Elrod, L M Cregar, S Sideris, R Rai, J W Janc.   

Abstract

Active site titration by a reversible tight-binding inhibitor normally depends on prior knowledge of the inhibition constant. Conversely, the determination of tight-binding inhibition constants normally requires prior knowledge of the active enzyme concentration. Often, neither of these quantities is known with sufficient accuracy. This paper describes experimental conditions under which both the enzyme active site concentration and the tight-binding inhibition constant can be determined simultaneously from a single dose-response curve. Representative experimental data are shown for the inhibition of human kallikrein. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038272     DOI: 10.1006/abio.2000.4685

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

1.  Structural and inhibition analysis reveals the mechanism of selectivity of a series of aggrecanase inhibitors.

Authors:  Micky D Tortorella; Alfredo G Tomasselli; Karl J Mathis; Mark E Schnute; Scott S Woodard; Grace Munie; Jennifer M Williams; Nicole Caspers; Arthur J Wittwer; Anne-Marie Malfait; Huey-Sheng Shieh
Journal:  J Biol Chem       Date:  2009-07-08       Impact factor: 5.157

2.  A standard operating procedure for an enzymatic activity inhibition assay.

Authors:  Joana Smirnovienė; Lina Baranauskienė; Asta Zubrienė; Daumantas Matulis
Journal:  Eur Biophys J       Date:  2021-04-16       Impact factor: 1.733

3.  Public domain databases for medicinal chemistry.

Authors:  George Nicola; Tiqing Liu; Michael K Gilson
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

4.  Expression, purification, and characterization of human cystatin C monomers and oligomers.

Authors:  Tyler J Perlenfein; Regina M Murphy
Journal:  Protein Expr Purif       Date:  2015-09-25       Impact factor: 1.650

5.  Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.

Authors:  Prashanth Anamthathmakula; Jeffery A Erickson; Wipawee Winuthayanon
Journal:  Biol Reprod       Date:  2022-05-17       Impact factor: 4.161

6.  Development of an Efficient Enzyme Production and Structure-Based Discovery Platform for BACE1 Inhibitors.

Authors:  Yu-Chen Yen; Annalissa M Kammeyer; Katherine C Jensen; Jagannadharao Tirlangi; Arun K Ghosh; Andrew D Mesecar
Journal:  Biochemistry       Date:  2019-10-22       Impact factor: 3.162

7.  Expression and characterization of recombinant fungal acetyl-CoA carboxylase and isolation of a soraphen-binding domain.

Authors:  Stephanie C Weatherly; Sandra L Volrath; Tedd D Elich
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

8.  Structural analysis of caspase-1 inhibitors derived from Tethering.

Authors:  Tom O'Brien; Bruce T Fahr; Michelle M Sopko; Joni W Lam; Nathan D Waal; Brian C Raimundo; Hans E Purkey; Phuongly Pham; Michael J Romanowski
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-04-09

9.  Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase.

Authors:  Emma J Shanks; Han B Ong; David A Robinson; Stephen Thompson; Natasha Sienkiewicz; Alan H Fairlamb; Julie A Frearson
Journal:  Anal Biochem       Date:  2009-09-11       Impact factor: 3.365

10.  Inhibition of plasma kallikrein by a highly specific active site blocking antibody.

Authors:  Jon A Kenniston; Ryan R Faucette; Diana Martik; Stephen R Comeau; Allison P Lindberg; Kris J Kopacz; Gregory P Conley; Jie Chen; Malini Viswanathan; Niksa Kastrapeli; Janja Cosic; Shauna Mason; Mike DiLeo; Jan Abendroth; Petr Kuzmic; Robert C Ladner; Thomas E Edwards; Christopher TenHoor; Burt A Adelman; Andrew E Nixon; Daniel J Sexton
Journal:  J Biol Chem       Date:  2014-06-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.